BUSINESS● LOWAug 13 · Aug 13, 2026, 8:17 AM
Outlook Therapeutics slides after pricing $55M securities offering
Seeking Alpha Tech
Outlook Therapeutics' stock has declined following the pricing of its $55 million securities offering. This indicates a negative market reaction to the company's financial maneuver.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS19m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS30m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech